EA
DGX icon

Emerald Acquisition’s Quest Diagnostics DGX Stock Holding History

Emerald Acquisition’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$36.1M Buy
426,322
+23,150
+6% +$1.94M 0.07% 337
2016
Q2 		$32.8M Buy
+403,172
New +$30.7M 0.06% 382

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Emerald Acquisition's DGX Position: Q3 2016 in Review

Emerald Acquisition increased its Quest Diagnostics (DGX) stake by 5.7% in Q3 2016, buying an estimated $1.94M and bringing the position to 426,322 shares worth $36.1M. The position accounts for 0.07% of the portfolio, ranked #337.

Emerald Acquisition first reported a position in DGX in Q2 2016 and has held it in 2 quarters since. 559 funds tracked by Wall St. Rank hold DGX as of Q3 2016.

  • Emerald Acquisition held 426,322 shares of Quest Diagnostics worth $36.1M as of Q3 2016.
  • Emerald Acquisition bought 23,150 Quest Diagnostics shares in Q3 2016, an estimated $1.94M.
  • Quest Diagnostics made up 0.07% of Emerald Acquisition's portfolio in Q3 2016, its #337 holding.
  • Emerald Acquisition first reported a position in Quest Diagnostics in Q2 2016 and has held it in 2 quarters since.
  • 559 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.